Gerresheimer AG logo

Gerresheimer AG (GRRMF)

Market Open
5 Dec, 14:31
OTC PINK OTC PINK
$
51. 41
0
0%
$
1.74B Market Cap
29.23 P/E Ratio
5% Div Yield
0 Volume
5.32 Eps
$ 51.41
Previous Close
Day Range
51.41 51.41
Year Range
46.7 91.72
Want to track GRRMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 80 days
German packaging firm Gerresheimer exploring sale, Bloomberg News reports

German packaging firm Gerresheimer exploring sale, Bloomberg News reports

German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter.

Reuters | 10 months ago
Gerresheimer shares jump as activist investor buys over 5% stake

Gerresheimer shares jump as activist investor buys over 5% stake

Gerresheimer's shares rose as much as 6.8% on Wednesday after a regulatory filing showed activist investor Ricky Chad Sandler had bought a 5.43% stake in German medical packaging maker.

Reuters | 1 year ago
Gerresheimer AG (GRRMF) Q2 2024 Earnings Call Transcript

Gerresheimer AG (GRRMF) Q2 2024 Earnings Call Transcript

Gerresheimer AG (OTCPK:GRRMF) Q2 2024 Earnings Conference Call July 11, 2024 4:00 AM ET Company Participants Guido Pickert - IR Dietmar Siemssen - CEO Bernd Metzner - CFO Conference Call Participants Oliver Reinberg - Kepler Cheuvreux Victoria Lambert - Berenberg Oliver Metzger - ODDO Paul Knight - KeyBanc Annapurna Bain - Barclays Olivier Calvet - UBS Klaus Brune - Platow Verlag David Adlington - JPMorgan Edward Hall - Stifel Falko Friedrichs - Deutsche Bank Curtis Moiles - BNP Paribas Alexander Galitsa - Hauck Aufhauser Investment Banking Operator Ladies and gentlemen, welcome to the Gerresheimer AG's Q2 and First Half 2024 Results Conference Call. I am Charley, the Chorus Call operator.

Seekingalpha | 1 year ago
Gerresheimer core profit meets forecast on weight-loss drug deals pipeline

Gerresheimer core profit meets forecast on weight-loss drug deals pipeline

Germany's Gerresheimer posted second-quarter adjusted core profit in line with market expectations on Thursday, driven by the deal pipeline for its plastics and devices segment, which supplies makers of weight-loss drugs with autoinjector pens.

Reuters | 1 year ago